How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID). (2017)
Attributed to:
Phase I/II trial of lentiviral vector mediated gene therapy for Adenosine Deaminase deficiency
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s10875-017-0373-y
PubMed Identifier: 28194615
Publication URI: http://europepmc.org/abstract/MED/28194615
Type: Journal Article/Review
Volume: 37
Parent Publication: Journal of clinical immunology
Issue: 4
ISSN: 0271-9142